NO881502L - Rekombinante htlv-111-proteiner og anvendelser av disse. - Google Patents

Rekombinante htlv-111-proteiner og anvendelser av disse.

Info

Publication number
NO881502L
NO881502L NO88881502A NO881502A NO881502L NO 881502 L NO881502 L NO 881502L NO 88881502 A NO88881502 A NO 88881502A NO 881502 A NO881502 A NO 881502A NO 881502 L NO881502 L NO 881502L
Authority
NO
Norway
Prior art keywords
proteins
recombinant htlv
htlv
recombinant
Prior art date
Application number
NO88881502A
Other languages
English (en)
Other versions
NO881502D0 (no
Inventor
Debra Lynn
Kashayar Javaberian
William Thomas Mueller
John Farley
Original Assignee
Repligen Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repligen Corp filed Critical Repligen Corp
Publication of NO881502D0 publication Critical patent/NO881502D0/no
Publication of NO881502L publication Critical patent/NO881502L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO88881502A 1987-10-09 1988-04-07 Rekombinante htlv-111-proteiner og anvendelser av disse. NO881502L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10770387A 1987-10-09 1987-10-09

Publications (2)

Publication Number Publication Date
NO881502D0 NO881502D0 (no) 1988-04-07
NO881502L true NO881502L (no) 1989-04-10

Family

ID=22318013

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88881502A NO881502L (no) 1987-10-09 1988-04-07 Rekombinante htlv-111-proteiner og anvendelser av disse.

Country Status (10)

Country Link
EP (1) EP0311228A3 (no)
JP (1) JPH01193299A (no)
KR (1) KR890006672A (no)
AU (1) AU614535B2 (no)
DK (1) DK196088A (no)
FI (1) FI882741A (no)
IL (1) IL86153A0 (no)
NO (1) NO881502L (no)
NZ (1) NZ224393A (no)
PT (1) PT87207A (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763160A (en) * 1988-02-12 1998-06-09 United Biomedical, Inc. Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines
US5914109A (en) * 1990-06-15 1999-06-22 New York University Heterohybridomas producing human monoclonal antibodies to HIV-1
IL98845A0 (en) * 1990-07-19 1992-07-15 Merck & Co Inc Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them
CZ239694A3 (en) * 1992-04-01 1995-07-12 Merck & Co Inc Recombinant human antibody against hiv, cassette for expression, host cell and a pharmaceutical preparation against hiv
PT728015E (pt) 1992-06-18 2006-07-31 Creagen Inc Antigenes polipeptidicos combinatoriais
US5274122A (en) * 1992-10-15 1993-12-28 Merck & Co., Inc. Acidic derivatives of homocysteine thiolactone
DE4405810A1 (de) 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK171727B1 (da) * 1978-12-22 1997-04-14 Biogen Inc Rekombinante hepatitis B virus DNA-molekyler, værtsorganismer transformeret hermed, HBV-antigenspecifikke polypeptider, DNA-sekvenser kodende for HBV-antigenspecifikke polypeptider, metoder til påvisning af hepatitis B virus-antistoffer, metoder til fremstilling af nævnte DNA-molekyler, fremgangsmåder til fremstilling af nævnte polypeptider og midler til påvisning af HBV-infektion
JPS5761110A (en) * 1980-09-30 1982-04-13 Kitagawa Tekkosho:Kk Formation of columnar solidified portion in soft ground
AU8746582A (en) * 1981-09-02 1983-03-10 Biogen N.V. Hepatitis b virus e type antigen
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus

Also Published As

Publication number Publication date
EP0311228A2 (en) 1989-04-12
DK196088A (da) 1989-04-10
AU614535B2 (en) 1991-09-05
DK196088D0 (da) 1988-04-11
NZ224393A (en) 1990-08-28
FI882741A0 (fi) 1988-06-09
NO881502D0 (no) 1988-04-07
PT87207A (pt) 1989-07-31
IL86153A0 (en) 1988-11-15
AU2117388A (en) 1989-04-27
EP0311228A3 (en) 1990-05-02
KR890006672A (ko) 1989-06-15
JPH01193299A (ja) 1989-08-03
FI882741A (fi) 1989-04-10

Similar Documents

Publication Publication Date Title
DK568487D0 (da) Norstatin- og norcyclostatinholdige polypeptider og farmaceutiske praeparater indeholdende disse.
NO861234L (no) Fremgangsmaate for ekstraksjon og opprensing av proteiner.
DK299087D0 (da) Proteins and derivatives thereof
DK47285A (da) Renininhiberende peptider og anvendelsen deraf
DK535988D0 (da) Immunosuppressive peptider og anvendelsesmetoder
NO881658L (no) Biofunksjonelle proteiner.
NO882226L (no) Fibrinolytiske proteiner.
NO882917D0 (no) Fusjonsproteiner og partikler.
DK353788A (da) Polypeptidderivater
NO873216D0 (no) Rekombinante htlv-iii-proteiner og anvendelse derav.
NO881502L (no) Rekombinante htlv-111-proteiner og anvendelser av disse.
NO905561D0 (no) Proteiner og nukleinsyrer.
NO864830D0 (no) Koblingsanordning og anvendelse av denne.
DK354989D0 (da) Modificerede proteiner
DE3888715D1 (de) Reg-Gen und dadurch kodiertes Protein.
DK604589D0 (da) Peptider, og analysesaet med indhold af saadanne forbindelser
NO881501D0 (no) Rekombinante htlv-111 proteiner og anvendelse av disse.
NO882836D0 (no) Fremgangsmaate for kjemisk modifisering av protider (proteiner og peptider).
DK604689D0 (da) Peptider, og analysesaet med indhold af saadanne forbindelser
DK362088D0 (da) Fusionsproteiner og fusionsproteinpartikler
DK627389D0 (da) Proteiner og derivater deraf
LV5812A4 (lv) Polipeptida iegusanas panemiens ekspresijas vektors un dns secibas
ATE100146T1 (de) Fusionsproteine und -partikel.
IT8767012A0 (it) Peptidi anoressizzanti e ipotensivi
DK396988D0 (da) Peptider samt fremstilling og anvendelse heraf